Whalegun
Home

Scott N. Boyle, Chief Business Officer: C4 Therapeutics CCCC Sell · Filed 25/02/18

Trade details

Type
Insider sale
Amount
$2,107.35
Shares · price
669 sh · $3.15 a share
Held after
107,805 sh
Stock
C4 Therapeutics CCCC
Person
Scott N. BoyleChief Business Officer
Trade date
25/02/18
Filed
25/02/18
Days to filing
0 days

Sold 0.6% of holdings

Share of holding sold
0.6%

C4 Therapeutics trades, last 26 weeks

What else happened in C4 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Scott N. Boyle's recent trades

  • Scott N. Boyle

    Sell10b5-1 planC4 Therapeutics

    $1,544

    Filed 25/02/18